A similar observation was made when the analysis was performed on the unstratified breast cancer group (Figure S5C); here CCL5 expression had a less significant effect on the survival probabilities and the hazard ratio (HR) was higher compared to that observed in cases with TNBC (0.66 vs. 0.30). Here, CCL5 is linked to breast cancer.